The AXL inhibitor bemcentinib overcomes microenvironment‐mediated resistance to pioglitazone in acute myeloid leukemia.
Saved in:
| Title: | The AXL inhibitor bemcentinib overcomes microenvironment‐mediated resistance to pioglitazone in acute myeloid leukemia. |
|---|---|
| Authors: | Zhu, Jaja1,2 (AUTHOR), Guérineau, Hippolyte1 (AUTHOR), Lefebvre‐Fortané, Anne‐Margaux1 (AUTHOR), Largeaud, Laetitia2 (AUTHOR), Lambert, Juliette1,3 (AUTHOR), Rousselot, Philippe1,3 (AUTHOR), Boudouin, Maèva1 (AUTHOR), Calvo, Julien1 (AUTHOR), Prost, Stéphane1 (AUTHOR), Clauser, Sylvain1,2 (AUTHOR), Bardet, Valérie1,2 (AUTHOR) valerie.bardet@cea.fr |
| Source: | FEBS Journal. Jan2025, Vol. 292 Issue 1, p115-128. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
